Differentiated Mesenchymal Stem Cells for Sciatic Nerve Injury
- 491 Downloads
Sciatic nerve injury is common and may cause neurological deficits. Previous studies showed that administration of neurotrophic factors (NTFs), naturally occurring proteins that support the development and survival of neurons, preserved and protected damaged motor neuron in the injured sciatic nerve. We have been successful in converting bone marrow-derived mesenchymal stem cells into astrocyte-like cells that produce and secrete NTFs (NTF+ cells). These cells demonstrate typical astrocyte morphology, express characteristic astrocyte markers and secrete high levels of NTFs. We have already shown that these cells and their conditioned media can protect neurons in culture and in animal models of neurodegenerative diseases. In the current study we examined whether NTF+ cells are capable of rescuing motor neurons in a rat sciatic nerve injury model, where the right hind limb sciatic nerve was crushed. Rats were transplanted with NTF+ cells, MSCs or PBS into the lesion site. In rats injected with the NTF+ cells motor function was markedly preserved. Moreover, NTF+ cells significantly inhibited the degeneration of the neuromuscular junctions and preserved the myelinated motor axons. Our findings suggest that autologous therapeutic approach can alleviate signs of sciatic nerve injury and probably other neurological disorders.
KeywordsSciatic nerve injury Motor neuron Mesenchymal stem cells Neurotrophic factors
This work was preformed in partial fulfillment of the requirements for a Ph.D. degree for Michal Dadon. This work was supported, in part, by The Devora Eleonora Kirshman Fund for Research of Parkinson’s Disease, Tel Aviv University and by the Norma and Alan Aufzein chair of Research of Parkinson’s Disease.
The authors wish to thank Dr. Igor Tarasenko for his exceptional assistance with the animal model.
Conflict of Interest statement
The authors declare no potential conflicts of interest.
- 2.Amoh, Y., Kanoh, M., Niiyama, S., Hamada, Y., Kawahara, K., Sato, Y., et al. (2009). Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells. Journal of Cellular Biochemistry, 107(5), 1016–1020.PubMedCrossRefGoogle Scholar
- 4.Pan, H. C., Yang, D. Y., Ho, S. P., Sheu, M. L., Chen, C. J., Hwang, S. M., et al. (2009). Escalated regeneration in sciatic nerve crush injury by the combined therapy of human amniotic fluid mesenchymal stem cells and fermented soybean extracts, Natto. Journal of Biomedical Science, 16, 75.PubMedCrossRefGoogle Scholar
- 6.Fryer, H. J., Wolf, D. H., Knox, R. J., Strittmatter, S. M., Pennica, D., O’Leary, R. M., et al. (2000). Brain-derived neurotrophic factor induces excitotoxic sensitivity in cultured embryonic rat spinal motor neurons through activation of the phosphatidylinositol 3-kinase pathway. Journal of Neurochemistry, 74(2), 582–595.PubMedCrossRefGoogle Scholar
- 11.Mohajeri, H., Figlewicz, D., & Bohn, M. (1999). Intramuscular grafts of myoblasts genetically modified to secrete glial cell iine-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Human Gene Therapy, 10, 1853–1866.PubMedCrossRefGoogle Scholar
- 12.Sakowski, S. A., Schuyler, A. D., & Feldman, E. L. (2009). Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 10(2), 63–73.Google Scholar
- 16.Rabinovsky, E. D., Gelir, E., Gelir, S., Lui, H., Kattash, M., DeMayo, F. J., et al. (2003). Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 17(1), 53–55.Google Scholar
- 19.Wang, Y., Mao, X. O., Xie, L., Banwait, S., Marti, H. H., Greenberg, D. A., et al. (2007). Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience, 27(2), 304–307.Google Scholar
- 24.Karusis, D., Kasis, I., Kurkalli, B. G., & Slavin, S. (2008). Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. Journal of the Neurological Sciences, 265, 131–135.CrossRefGoogle Scholar
- 31.Pan, H. C., Cheng, F. C., Chen, C. J., Lai, S. Z., Lee, C. W., Yang, D. Y., et al. (2007). Post injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. Journal of Clinical Neuroscience, 14, 1089–1098.PubMedCrossRefGoogle Scholar
- 34.Cheng, F. C., Tai, M. H., Sheu, M. L., Chen, C. J., Yang, D. Y., Su, H. L., et al. (2009). Enhancement of regeneration with glia cell line-derived neurotrophic factor-transduced human amniotic fluid mesenchymal stem cells after sciatic nerve crush injury. Journal of Neurosurgery, 112(4), 868–879.CrossRefGoogle Scholar
- 35.Suzuki, M., McHugh, J., Tork, C., Shelley, B., Hayes, A., Bellantuono, I., et al. (2008). Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Molecular Therapy: the Journal of the American Society of Gene Therapy, 16(12), 2002–2010.Google Scholar
- 37.Barhum, Y., Gai-Castro, S., Bahat-Stromza, M., Barzilay, R., Melamed, E., & Offen, D. (2010). Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. Journal of Molecular Neuroscience, 41(1), 129–137.PubMedCrossRefGoogle Scholar
- 38.Bahat-Stroomza, M., Barhum, Y., Levy, Y. S., Karpov, O., Bulvik, S., Melamed, E., et al. (2009). Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson’s disease. Journal of Molecular Neuroscience, 39(1–2), 199–210.PubMedCrossRefGoogle Scholar